EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

CROSS SECTIONAL STUDY ON DIRECT AND INDIRECT COSTS INCURRED TOWARDS DOTS TREATMENT BY TUBERCULOSIS PATIENTS IN BENGALURU CITY

Dr. Prasad K. N.* and Puttaswamy M.

ABSTRACT

Background: There are innumerable costs involved in treatment of Tuberculosis. There are costs which are contributed by patients or his relative towards treatment other than availing free TB Medicines. Objective: To estimate the direct and indirect cost incurred towards DOTS treatment of Tuberculosis in Bangalore city. Methodology: A cross sectional, community based, descriptive and explorative study was conducted among all TB cases registered for treatment in randomly selected 4 DOT centers during September and October 2016 in Bangalore city. The pilot tested, pre designed and semi open ended questionnaire was used to collect information from TB patients at their door steps by direct interview. The data contained information about patients’ socio economic details, transport mode and costs, absent for work and loss of earnings, accompanying persons work, income and absent for work details. The data was analysed in SPSS version 20. Results: There were 64 male and 48 female TB patients on treatment during the study period. The mean age of TB patient was 35.8+16.1 years. There were more number of male patients in category I, pulmonary and Intensive phase period of treatment Majority used their own vehicle to reach DOT centers which is less than 2 km distance. The costs were not calculated for homemakers and travelling to DOT centers by walking. The total absent days for work among TB patients was 3178. The crude loss of pay per day per person for TB patients and accompanying person were Rs 633 and Rs 431 respectively. The adjusted loss of pay for TB patients was Rs 341 per day per person. Conclusion: The direct cost is resulting from TB patients visiting DOT centre as one way was approximately Rs 20 per day. The indirect costs were estimated to be Rs.46842 per day among working class of patients except for homemaker. This economic loss to the families of TB patients is enormous irrespective of free treatment and subsidized provisions.

Keywords: Tuberculosis, Direct cost, indirect cost, loss of pay, earnings, crude, adjusted.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )